BNTC - Benitec Biopharma Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 15.65

Open

$ 15.70

Bid

$ 15.65 x 5

Ask

$ 16.31 x 100

Day's Range

$ 15.21 - $ 15.96

52 Week Range

$ 9.10 - $ 17.15

Volume

33,476

Average Volume

Market Cap

410.82M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	09-22-2025	06-30-2025	10-K
2	05-14-2025	03-31-2025	10-Q
3	02-14-2025	12-31-2024	10-Q
4	11-14-2024	09-30-2024	10-Q
5	09-26-2024	06-30-2024	10-K
6	05-13-2024	03-31-2024	10-Q
7	02-13-2024	12-31-2023	10-Q
8	11-13-2023	09-30-2023	10-Q
9	09-21-2023	06-30-2023	10-K
10	05-15-2023	03-31-2023	10-Q
11	02-13-2023	12-31-2022	10-Q
12	11-10-2022	09-30-2022	10-Q
13	09-02-2022	06-30-2022	10-K
14	05-16-2022	03-31-2022	10-Q
15	02-14-2022	12-31-2021	10-Q
16	11-15-2021	09-30-2021	10-Q
17	09-20-2021	06-30-2021	10-K
18	05-12-2021	03-31-2021	10-Q
19	02-09-2021	12-31-2020	10-Q
20	11-13-2020	09-30-2020	10-Q
21	09-23-2020	06-30-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JMP Securities Reiterates Market Outperfor...
09/24/2025 13:02:39

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20...

Benitec Biopharma Files For Mixed Shelf Of...
09/22/2025 21:27:18

-SEC Filing

CORRECTION: Benitec Biopharma Q4 EPS $(0.4...
09/22/2025 21:12:13

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $...

Oppenheimer Maintains Outperform on Benite...
09/16/2025 15:56:21

Oppenheimer analyst Andreas Argyrides maintains Benitec Biopharma (NASDAQ:BNTC) with a Outperform and lowers the price targe...

Benitec Biopharma Receives Green Light To ...
07/09/2025 12:18:04

-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinic...

HC Wainwright & Co. Reiterates Buy on Beni...
05/19/2025 11:15:14

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 p...

JMP Securities Reiterates Market Outperfor...
05/15/2025 13:45:53

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20...

Benitec Biopharma Q3 EPS $(0.24) Beats $(0...
05/14/2025 12:13:51

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0...

JMP Securities Maintains Market Outperform...
04/10/2025 13:18:43

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

HC Wainwright & Co. Reiterates Buy on Beni...
03/24/2025 11:01:18

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 p...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
03/21/2025 12:10:22

Benitec Biopharma Reports Interim Clinical...
03/19/2025 11:12:34

Citizens Capital Markets Reiterates Market...
03/18/2025 14:30:17

Citizens Capital Markets analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and mai...

HC Wainwright & Co. Reiterates Buy on Beni...
02/21/2025 12:36:10

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 p...

Benitec Biopharma Q2 2025 GAAP EPS $(0.33)...
02/14/2025 13:11:23

Benitec Biopharma's Megan Boston Confirmed...
12/13/2024 21:23:31

- SEC Filing

Baird Initiates Coverage On Benitec Biopha...
12/13/2024 09:15:17

Baird analyst Brian Skorney initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Pri...

Guggenheim Reiterates Buy on Benitec Bioph...
12/03/2024 16:40:34

Guggenheim analyst Debjit Chattopadhyay reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $17 price target.

Benitec Biopharma Q1 2025 GAAP EPS $(0.48)...
11/14/2024 22:19:50

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0...

Benitec Biopharma Files For Mixed Shelf Of...
11/01/2024 21:09:27

- SEC Filing